Exposure of the yeast Candida albicans to the anti‐neoplastic agent adriamycin increases the tolerance to amphotericin B
Exposure of the yeast Candida albicans to the anti‐neoplastic agent adriamycin increases the tolerance to amphotericin B
复制标题
DOI:
10.1211/0022357022359
复制
发表时间:
2003-12
影响因子:
3.3
通讯作者:
Joseph O'Keeffe;S. Doyle;K. Kavanagh
中科院分区:
文献类型:
--
作者:
Joseph O'Keeffe;S. Doyle;K. Kavanagh
Cancer patients experience a high incidence of fungal infections due to their immuno‐suppressed condition. This work has investigated the interaction of an anti‐neoplastic agent, adriamycin (doxorubicin), with the yeast Candida albicans and examined whether this drug altered the susceptibility of the yeast to amphotericin B – an anti‐fungal agent used for the treatment of systemic fungal infections in cancer patients. Exposure to adriamycin for 24 h increased the growth of C. albicans and increased the tolerance to amphotericin B by a small, but statistically significant, extent. Growth in adriamycin‐supplemented medium suppressed the respiration rate of C. albicans, which resulted in a decrease in the ergosterol content of the fungal cell membrane. The tolerance to amphotericin B was lost after exposure to adriamycin for 48 h, which coincided with a restoration in the respiration rate and the ergosterol content of the fungal cell membrane. This work demonstrated that short‐term exposure (24 h) to adriamycin increased the tolerance of C. albicans for amphotericin B, which may be mediated by a decrease in the ergosterol content as a result of an adriamycin‐induced disruption of oxidative phosphorylation.